Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Fujita, I. Inoshima, E. Harada, H. Ouchi, S. Ikegame, Y. Nakanishi, K. Watanabe (Fukuoka, Japan). Impaired host defense against Mycobacterium avium in mice with chronic granulomatous disease. Eur Respir J 2008; 32: Suppl. 52, 2853

Member's Comments

No comment yet.

Related content which might interest you: Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection Source: Eur Respir J 2015; 46: 1823-1826 Year: 2015 Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease Source: Eur Respir J 2005; 26: 1092-1096 Year: 2005 Susceptibility to nontuberculous mycobacterial lung disease Source: Eur Respir J 2008; 31: 1322-1333 Year: 2008 Clinical relevance of Mycobacterium simiae in pulmonary samples Source: Eur Respir J 2008; 31: 106-109 Year: 2008 Paradoxical response during antibiotic treatment in patients with Mycobacterium avium complex lung disease Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis Year: 2020 Factors related to response to intermittent treatment of mycobacterium avium complex lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 557s Year: 2006 Antibody testing for Mycobacterium avium complex infection in cystic fibrosis patients Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments Year: 2018 Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Apoptosis plays a protective role against Mycobacterium avium infection in mice Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017 Immune defects in patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis Source: ERJ Open Res, 6 (4) 00590-2020; 10.1183/23120541.00590-2020 Year: 2020 Mycobacterium abscessus respiratory infection: importance in immunosuppressed patients Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021 Year: 2022 Drug resistance of Mycobacterium tuberculosis isolated from tuberculosis inflammatory foci Source: Eur Respir J 2005; 26: Suppl. 49, 654s Year: 2005 Serodiagnosis of Mycobacterium abscessus complex infection in cystic fibrosis Source: Eur Respir J 2015; 46: 707-716 Year: 2015 Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019 Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA Source: Eur Respir J 2013; 42: 454-460 Year: 2013 Pulmonary infection with Mycobacterium avium in immunocompetent children without IFN-γ (interferon-gamma) or IL-12-receptor deficiency Source: Eur Respir J 2001; 18: Suppl. 33, 511s Year: 2001 Subtle immunodeficiencies in nodular–bronchiectatic Mycobacterium avium complex lung disease Source: ERJ Open Res, 6 (4) 00548-2020; 10.1183/23120541.00548-2020 Year: 2020 Clinical relevance of differentiation between Mycobacterium avium and M. intracellulare in M. avium complex pulmonary disease in Croatia Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities Year: 2019